Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer
Open Access
- 1 June 2021
- journal article
- research article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 22 (6) , 1949-1955
Abstract
Objective: Lung cancer is one of the most prevalent cancers and the leading cause of cancer-related deaths worldwide. MicroRNAs regulate more than 60% of human genes, including tumor suppressor genes and oncogenes. Accordingly, they can affect cancer risk. This study aimed to evaluate the role of serum miR-148a as a non-invasive biomarker in non-small cell lung cancer (NSCLC) patients and to assess the correlation between miR-148a and Bcl-2, as one of its target proteins. Materials and Methods: A total of 50 newly diagnosed NSCLC cases and 30 apparently healthy controls were recruited in this study. MiR-148a level was measured by TaqMan- Real time RT-PCR assay and Bcl-2 level was measured by ELISA. Results: Significant lower expression of serum miR-148a and higher serum Bcl-2 levels were observed in NSCLC patients as compared to the control group (pKeywords
This publication has 36 references indexed in Scilit:
- MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signalingOncogene, 2013
- MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2Tumor Biology, 2013
- The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal CancerPLOS ONE, 2012
- MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric CancerClinical Cancer Research, 2011
- MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancerCell Death & Differentiation, 2011
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 ExpressionJournal of Biological Chemistry, 2010
- MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinomaBritish Journal of Surgery, 2010
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001